Breast

ASCO Clinical Practice Guideline Adds BCI to Guide Extended Endocrine Therapy Decisions

The ASCO has expanded the utility of BCI in its guideline: “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.”

Breast

Epic Sciences Launches Blood-Based Test for Metastatic Breast Cancer Patients

The novel metastatic breast cancer test includes both cell-based and cell-free analysis from a single blood draw.

Breast

Roche and Ibex to Collaborate on AI-Based Digital Pathology Applications

Roche has entered an agreement with Ibex Medical Analytics, a provider of artificial intelligence (AI)-based cancer diagnostics.

This Breast Cancer Gene Is Less Well Known, but Nearly as Dangerous

Aug 17, 2021 | Breast

As part of their regular breast health screening, many women are routinely tested for the BRCA1 and BRCA2 mutations. They should also be tested for PALB2.

Women of all Ancestries Can Now Assess Their Genetic Breast Cancer Risk

Aug 2, 2021 | Breast

Myriad Genetics, Inc., has launched a new version of its MyRisk Hereditary Cancer Test. Women of all ancestries can assess breast cancer risk.

Mayo Clinic Research Suggests Women Over 65 Be Offered Hereditary Cancer Genetic Testing

Jul 23, 2021 | Breast

The study results suggest that perhaps all women with breast cancer, including those diagnosed over age 65, should be offered hereditary breast cancer testing.

Black and White Women Have Same Mutations Linked to Breast Cancer Risk

Jun 21, 2021 | Breast

“The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” says first author Susan Domchek, MD.

New Biosensor Developed to Aid Early Diagnosis of Breast Cancer

May 28, 2021 | Breast

The mesoporous biosensor developed to detect breast cancer is easy to use, low cost, and provides results in a very short time—between 30 and 60 minutes—from a sample of the patient’s plasma.

Webinar: Detecting PI3K Signaling Pathway Mutations

May 18, 2021 | Breast

Resistance to breast cancer therapy and disease progression may result from activation of the PI3K pathway.

Biomarker Assay Identifies DCIS Patients at Increased Risk for Breast Cancer-Specific Death

Mar 15, 2021 | Breast, Immunoassay

The DCISionRT Decision Score from PreludeDx was significantly associated with breast cancer mortality while clinicopathologic factors were not.

Breast Cancer HER2 Control Cell Line Array

Mar 8, 2021 | Breast

This new FFPE cell pellet microarray delivers a full dynamic range of HER2, ER, and PR expression, validated by the Ventana system.

Mayo Clinic Researchers Develop Test to Measure Effect of Breast Cancer Gene Variants

Mar 3, 2021 | Breast

The lead researcher says the results will have a positive effect on patient care because patients will know whether breast cancer VUS are benign or pathogenic.

HiberCell, Biodesix Partner on ELISA CDx for Cancer Immunotherapy

Jan 13, 2021 | Breast, Diagnostic Technologies

Through this agreement, Biodesix will develop a companion diagnostic to select patients for enrollment in HiberCell’s future registrational clinical trials.

Roche Launches 2 Digital Pathology Image Analysis Algorithms for Precision Breast Cancer Diagnosis

Jan 11, 2021 | Breast, Digital Imaging

uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer use AI to aid pathologists’ decision-making.

Hologic to Acquire Molecular Diagnostics Company Biotheranostics

Jan 5, 2021 | Breast, Company News, Molecular Diagnostics

Biotheranostics is a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers.

Oncotype DX Test Can Spare Chemotherapy for Women with Certain Breast Cancers

Dec 21, 2020 | Breast

Data from RxPONDER trial successfully defined the benefit of chemotherapy in early-stage, node-positive breast cancer patients with Oncotype DX Breast Recurrence Score results of 0 to 25.